Ron Burgundy Posted July 15, 2014 Share Posted July 15, 2014 By Caroline Copley ZURICH (Reuters) - Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics to track their blood glucose levels or restore the eye's ability to focus. The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The technology is potentially life-changing for many diabetics, who prick their fingers as many as 10 times daily to check their body's production of the sugar. Success would allow Novartis to compete in a global blood-sugar tracking market that is expected to be worth more than $12 billion by 2017, according to research firm GlobalData. View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.